July 26, 2013
Chugai Pharmaceutical announced on July 25 that it posted sales of 201,016 million yen for the January-June 2013 period (up 8.4%, compared to the same period last year), thanks to a sales increase of anticancer drugs including Avastin (bevacizumab), and...read more